10.6%) in favor of Magmaris, but it did not reach statistical significance at the 2-year follow-up ( p = 0.112).
← all excerpts
Two-Year Outcomes for Patients with Non-ST-Elevation Acute Coronary Syndrome Treated with Magmaris and Absorb Bioresorbable Scaffolds in Large-Vessel Lesions.
1
0.1120
0.1120